1-Pyrrolidineaceticacid, 2,5-dioxo
Modify Date: 2025-08-29 10:12:27
1-Pyrrolidineaceticacid, 2,5-dioxo structure
|
Common Name | 1-Pyrrolidineaceticacid, 2,5-dioxo | ||
|---|---|---|---|---|
| CAS Number | 5626-41-5 | Molecular Weight | 157.12400 | |
| Density | 1.496g/cm3 | Boiling Point | 457ºC at 760mmHg | |
| Molecular Formula | C6H7NO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 230.2ºC | |
| Name | 2-(2,5-dioxopyrrolidin-1-yl)acetic acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.496g/cm3 |
|---|---|
| Boiling Point | 457ºC at 760mmHg |
| Molecular Formula | C6H7NO4 |
| Molecular Weight | 157.12400 |
| Flash Point | 230.2ºC |
| Exact Mass | 157.03800 |
| PSA | 74.68000 |
| Index of Refraction | 1.544 |
| InChIKey | ZQBWYXZRSMMISZ-UHFFFAOYSA-N |
| SMILES | O=C(O)CN1C(=O)CCC1=O |
| HS Code | 2925190090 |
|---|
|
~%
1-Pyrrolidineac... CAS#:5626-41-5 |
| Literature: AstraZeneca AB Patent: EP1075261 B1, 2006 ; Location in patent: Page/Page column 14 ; |
|
~92%
1-Pyrrolidineac... CAS#:5626-41-5 |
| Literature: Bansode, Tanaji N.; Shelke, Jayant V.; Dongre, Vaijanath G. European Journal of Medicinal Chemistry, 2009 , vol. 44, # 12 p. 5094 - 5098 |
|
~63%
1-Pyrrolidineac... CAS#:5626-41-5 |
| Literature: Kaminski, Krzysztof; Rzepka, Sabina; Obniska, Jolanta Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 19 p. 5800 - 5803 |
![1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-dione structure](https://image.chemsrc.com/caspic/207/65349-00-0.png)
CAS#:65349-00-0
CAS#:5694-33-7| HS Code | 2925190090 |
|---|---|
| Summary | 2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
Name: A screen for compounds that inhibit cell wall-associated teichoic acid synthesis in S...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: N/A
External Id: HMS704
|
|
Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: HCMV UL50
External Id: HMS1262
|
|
Name: Screen for inhibitors of RMI FANCM (MM2) intereaction
Source: 11908
Target: N/A
External Id: RMI-FANCM-MM2
|
|
Name: Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: ORF 73 [Human herpesvirus 8 type M]
External Id: HMS791
|
|
Name: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Non-Small Cell L...
Source: DTP/NCI
Target: N/A
External Id: MCF7_OneDose
|
|
Name: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Non-Small Cell...
Source: DTP/NCI
Target: N/A
External Id: IGROV1_OneDose
|
|
Name: High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS1303
|
|
Name: A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS979
|
|
Name: A screen for compounds that inhibit viral RNA polymerase binding and polymerization a...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: Chain A, Poliovirus Polymerase With Gtp
External Id: HMS750
|
Total 9, Current Page 1 of 1
1
| succinimido-acetic acid |
| N-Succinylglycine |
| 1-Pyrrolidineacetic acid,2,5-dioxo |
| N,N-succinyl-glycine |
| N,N-Succinyl-glycin |
| N-succinoyl-glycine |